Malin Andersson
Universitetslektor vid Institutionen för farmaceutisk biovetenskap; Forskning; Toxikologi och läkemedelssäkerhet
- Telefon:
- 018-471 46 39
- Mobiltelefon:
- 073-469 79 15
- E-post:
- Malin.Andersson@farmbio.uu.se
- Besöksadress:
- Uppsala biomedicinska centrum BMC, Husarg. 3
- Postadress:
- Box 591
751 24 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
ResearcherID: A-9930-2009
Research group:
http://www.farmbio.uu.se/forskning/researchgroups/dst/Neurotoxikologi/
Publikationer
Urval av publikationer
- MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease (2012)
- L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry (2011)
- Putaminal Upregulation of FosB/ΔFosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia (2011)
- Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease (2011)
- Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry (2010)
Senaste publikationer
- Perinatal exposure to a glyphosate-based herbicide causes dysregulation of dynorphins and an increase of neural precursor cells in the brain of adult male rats (2021)
- Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry (2017)
- Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1 (2017)
- Opioid precursor protein isoform is targeted to the cell nuclei in the human brain (2017)
- Intra- and interregional coregulation of opioid genes (2017)
Alla publikationer
Artiklar
- Perinatal exposure to a glyphosate-based herbicide causes dysregulation of dynorphins and an increase of neural precursor cells in the brain of adult male rats (2021)
- Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry (2017)
- Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1 (2017)
- Opioid precursor protein isoform is targeted to the cell nuclei in the human brain (2017)
- Intra- and interregional coregulation of opioid genes (2017)
- Neuropeptide imaging in rat spinal cord with MALDI-TOF MS (2017)
- Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization (2016)
- Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar Consumption (2016)
- Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA) (2014)
- MALDI Imaging of Post Mortem Human Spinal Cord in Amyotrophic Lateral Sclerosis (2013)
- Analysis of neuropeptides by MALDI imaging mass spectrometry (2013)
- Neurotoxin-induced fibril formation and protein changes in rodents (2012)
- MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease (2012)
- Neonatal Exposure to the Cyanobacterial Toxin BMAA Induces Changes in Protein Expression and Neurodegeneration in Adult Hippocampus (2012)
- L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry (2011)
- MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue (2011)
- Putaminal Upregulation of FosB/ΔFosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia (2011)
- Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease (2011)
- Alterations of striatal dynorphin peptide levels associated with L-DOPA-induced dyskinesia elucidated by imaging mass spectrometry (2010)
- Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry (2010)
- Heat stabilization of the tissue proteome (2009)
- Imaging mass spectrometry of proteins and peptides (2008)
- Identification of proteins directly from tissue (2007)
- Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. (2007)
- A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. (2006)
- Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. (2006)
- Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. (2003)
- Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. (2002)
- cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. (2001)
- Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia. (2001)
- Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. (2001)
- Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. (1999)
- Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment. (1999)
- MALDI Imaging of Post Mortem Spjnal Cord in Amyotrophic Lateral Sclerosis
- Imaging mass spectrometry reveals association of nigral levels of dynorphin peptides and L-DOPA-induced dyskinesia in Parkinson’s disease
- LONG-TERM MORPHOLOGICAL AND PROTEIN CHANGES IN THE BRAIN OF ADULT RATS NEONATALLY TREATED WITH THE ENVIRONMENTAL TOXIN β-N-METHYLAMINO-L-ALANINE (BMAA)
- Tracking distributions of inhaled compounds within tissue com-partments using MALDI imaging mass spectrometry
